172 filings
10-Q
2024 Q1
ZVSA
ZyVersa Therapeutics Inc
Quarterly report
15 May 24
8:30am
10-K/A
2023 FY
ZVSA
ZyVersa Therapeutics Inc
Annual report (amended)
15 May 24
8:25am
8-K
ZVSA
ZyVersa Therapeutics Inc
25 Apr 24
Material Modifications to Rights of Security Holders
4:30pm
8-K
ZVSA
ZyVersa Therapeutics Inc
17 Apr 24
Submission of Matters to a Vote of Security Holders
4:30pm
DEFA14A
ZVSA
ZyVersa Therapeutics Inc
27 Mar 24
Additional proxy soliciting materials
5:00pm
8-K
0kw2hez
8 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
kz0kh
1 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
S-8
npxn27dlhf
14 Feb 24
Registration of securities for employees
4:34pm
8-K
wnpp 7offbt5od8k
22 Dec 23
Changes in Registrant's Certifying Accountant
4:45pm
8-K
tcpvpjbkl
11 Dec 23
ZyVersa Therapeutics, Inc. Announces Pricing of $5.0 Million Public Offering
4:30pm
424B4
xwxvspm le
8 Dec 23
Prospectus supplement with pricing info
4:44pm
EFFECT
nedv6i8pvo8dk o9bp
7 Dec 23
Notice of effectiveness
12:15am
CORRESP
cn029kjvr818mj
6 Dec 23
Correspondence with SEC
12:00am
CORRESP
iefq3pll cy4o75s3
6 Dec 23
Correspondence with SEC
12:00am
8-K
febxikbp2304bvm4zcc
30 Nov 23
ZyVersa Therapeutics, Inc. Announces Reverse Stock Split and Increase in Authorized Shares of Common Stock
11:45am